A condition that compels people to move their legs could indicate they have a greater chance of developing Parkinson's ...

As of 9:40 a.m. on October 14, the share price of S-Biomedics on the KOSDAQ market was up 8.15% from the previous day's closing price, reaching 29,850 ...

CHENGDU, China, Oct. 13, 2025 /PRNewswire/ -- iRegene Therapeutics Co., Ltd. ("iRegene" or the "Company") is recognized as a biotechnology company ...

FDA clears path for Phase 3 testing following positive Type B meeting Regulatory alignment confirms preclinical data sufficient for pivotal ...

This 3-part series looks at the current evidence for the treatment of SUD, alcohol use disorder, and tobacco use disorder.

A new study of over 9,900 people with restless leg syndrome (RLS) has suggested that the condition appears to increase the risk of developing Parkinson’s disease (PD). RLS is a neurological condition ...

This study reveals that glycine decarboxylase (GLDC) promotes IgA nephropathy (IgAN) progression by enhancing mesangial cell ...

Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform ™ drug optimization technology, today announced the launch of ...

Detailed price information for Serina Therapeutics Inc (SER-A) from The Globe and Mail including charting and trades.

Individual differences in emotional learning underpinning vulnerabilities to compulsive reward-seeking behaviors. Dr. Eva Pool - FNS Ambizione. Research question: A variety of psy ...

Precision medicine holds enormous promise in enhancing treatment efficacy and advancing therapeutic development, leading to more equitable care. However, to realise this promise in all individuals ...